Clinical Trial

Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease

Study acronym: REMedy

Recruiting

Record status

This record was last updated February 13, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Summary

This study examines the feasibility and acceptability of a mindfulness-based mobile intervention designed to support pain and sleep management among adolescents and young adults with sickle cell disease. Chronic pain and sleep problems are common in this population and can negatively affect daily functioning and quality of life. Participants will use a smartphone-based mindfulness program that includes structured modules and guided mindfulness exercises over an approximately 8-week period. The study aims to evaluate whether the intervention is feasible and acceptable for adolescents and young adults with sickle cell disease.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-03.

Trial Details

NCT Number	NCT07402811
Lead Sponsor	University of Illinois at Chicago Collaborators: National Institute of Nursing Research (NINR)
Conditions	Chronic Pain, Sickle Cell Disease, Sleep Disturbance
Enrollment	20 participants
Start Date	2025-12-06
Primary Completion	2026-05 (estimated)
Study Completion	2026-05 (estimated)
Updated on ClinicalTrials.gov	2026-02-13